Activation of human nuclear receptors by perfluoroalkylated substances (PFAS)

A new mathematical model for relative quantification in real-time RT-PCR

Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610

Perfluoroalkyl Acids: A Review of Monitoring and Toxicological Findings

Lau, C., Anitole, K., Hodes, C., Lai, D., Pfahles-Hutchens, A., & Seed, J. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm128 · Cited by 2,620

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ

Kliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble, C. S., Devchand, P., Wahli, W., Willson, T. M., Lenhard, J. M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4318 · Cited by 2,164

Polyfluoroalkyl Chemicals in the U.S. Population: Data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and Comparisons with NHANES 1999–2000

Calafat, A. M., Wong, L.-Y., Kuklenyik, Z., Reidy, J. A., & Needham, L. L. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.10598 · Cited by 1,247

Peroxisome Proliferator-Activated Receptor Alpha Target Genes

Rakhshandehroo, M., Knoch, B., Müller, M., & Kersten, S. (2010) · PPAR Research · doi:10.1155/2010/612089 · Cited by 1,020

Perfluorinated compounds – Exposure assessment for the general population in western countries

Fromme, H., Tittlemier, S. A., Völkel, W., Wilhelm, M., & Twardella, D. (2008) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2008.04.007 · Cited by 979

The Developmental Toxicity of Perfluoroalkyl Acids and Their Derivatives

Lau, C., Butenhoff, J. L., & Rogers, J. M. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2003.11.031 · Cited by 867

Trends in Exposure to Polyfluoroalkyl Chemicals in the U.S. Population: 1999−2008

Kato, K., Wong, L.-Y., Jia, L. T., Kuklenyik, Z., & Calafat, A. M. (2011) · Environmental Science & Technology · doi:10.1021/es1043613 · Cited by 777

The toxicology of perfluorooctanoate

Kennedy, G. L., Butenhoff, J. L., Olsen, G. W., O'Connor, J. C., Seacat, A. M., Perkins, R. G., Biegel, L. B., Murphy, S. R., & Farrar, D. G. (2004) · Critical Reviews in Toxicology · doi:10.1080/10408440490464705 · Cited by 742

Perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS) in surface waters, sediments, soils and wastewater – A review on concentrations and distribution coefficients

Zareitalabad, P., Siemens, J., Hamer, M., & Amelung, W. (2013) · Chemosphere · doi:10.1016/j.chemosphere.2013.02.024 · Cited by 642

Per- and Polyfluoroalkyl Substances (PFAS) Enhance Cholesterol Accumulation and Dysregulate Inflammatory Responses in Macrophages

Connolly, J. C., Ishihara, Y., Sawaya, E., Whitfield, V., Garrity, N., Sohata, R., Tsymbal, M., Lundberg, A., Merrill, M. A. L., DeWitt, J. C., et al. (2025) · Cardiovascular Toxicology · doi:10.1007/s12012-025-10048-w · Cited by 27

Lipoprotein profiles associated with exposure to poly- and perfluoroalkyl substances (PFASs) in the EuroMix human biomonitoring study

Papadopoulou, E., Nicolescu, A. F., Haug, L. S., Husøy, T., Deleanu, C., Dirven, H. A. A. M., & Lindeman, B. (2022) · Environmental Pollution · doi:10.1016/j.envpol.2022.119664 · Cited by 24

Exposure to high levels of PFAS through drinking water is associated with increased risk of type 2 diabetes—findings from a register-based study in Ronneby, Sweden

Xu, Y., Jakobsson, K., Harari, F., Andersson, E. M., & Li, Y. (2023) · Environmental Research · doi:10.1016/j.envres.2023.115525 · Cited by 30

Exposure to a PFOA, PFOS and PFHxS Mixture during Gestation and Lactation Alters the Liver Proteome in Offspring of CD-1 Mice

Kaye, E. M., Marques, E., Areiza, J. A., Modaresi, S. M. S., & Slitt, A. L. (2024) · Toxics · doi:10.3390/toxics12050348 · Cited by 25

Assessing the impact of perfluoroalkyl substances on liver health: a comprehensive study using multi-donor human liver spheroids

Golden‐Mason, L., Salomon, M. P., Matsuba, C., Wang, Y., Setiawan, V. W., Chatzi, L., & Maretti-Mira, A. C. (2025) · Environment International · doi:10.1016/j.envint.2025.109763 · Cited by 25

Increased toxicity and retention of perflourooctane sulfonate (PFOS) in humanized CYP2B6-Transgenic mice compared to Cyp2b-null mice is relieved by a high-fat diet (HFD)

Hamilton, M. C., Heintz, M. M., Pfohl, M., Marques, E., Ford, L. C., Slitt, A. L., & Baldwin, W. S. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.112175 · Cited by 24

Bovine oocyte exposure to perfluorohexane sulfonate (PFHxS) induces phenotypic, transcriptomic, and DNA methylation changes in resulting embryos in vitro

Hallberg, I., Persson, S., Olovsson, M. H., Moberg, M., Ranefall, P., Laskowski, D., Damdimopoulou, P., Sirard, M., Rüegg, J., & Sjunnesson, Y. C. B. (2022) · Reproductive Toxicology · doi:10.1016/j.reprotox.2022.02.004 · Cited by 25

Assessment of the mode of action underlying development of liver lesions in mice following oral exposure to HFPO-DA and relevance to humans

Heintz, M. M., Haws, L. C., Klaunig, J. E., Cullen, J. M., & Thompson, C. M. (2023) · Toxicological Sciences · doi:10.1093/toxsci/kfad004 · Cited by 23

PFOS-elicited metabolic perturbation in liver and fatty acid metabolites in testis of adult mice

Lee, W. K., Lam, T. K. Y., Tang, H. C., Ho, T. C., Wan, H. T., & Wong, C. K. C. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1302965 · Cited by 22

Associations between PFAS occurrence and multimorbidity as observed in an electronic health record cohort

Ward-Caviness, C. K., Moyer, J., Weaver, A. M., Devlin, R. B., & Díaz-Sánchez, D. (2022) · Environmental Epidemiology · doi:10.1097/ee9.0000000000000217 · Cited by 22

Gene–Environment Interactions in the Associations of PFAS Exposure with Insulin Sensitivity and Beta-Cell Function in a Faroese Cohort Followed from Birth to AdulthoodPreprint

Valvi, D., Christiani, D. C., Coull, B. A., Højlund, K., Nielsen, F., Audouze, K., Su, L., Weihe, P., & Grandjean, P. (2022) · SSRN Electronic Journal · doi:10.1016/j.envres.2023.115600 · Cited by 24

Characterization of Potential Adverse Outcome Pathways Related to Metabolic Outcomes and Exposure to Per- and Polyfluoroalkyl Substances Using Artificial Intelligence

Kaiser, A.-M., Jeddi, M. Z., Uhl, M., Jornod, F., Fernández, M. F., & Audouze, K. (2022) · Toxics · doi:10.3390/toxics10080449 · Cited by 21

Pregnancy urinary concentrations of bisphenol A, parabens and other phenols in relation to serum levels of lipid biomarkers: Results from the EARTH study

Mínguez‐Alarcón, L., Frueh, L., Williams, P. L., James-Todd, T. M., Souter, I. C., Ford, J. B., Rexrode, K. M., Calafat, A. M., Hauser, R. B., & Chavarro, J. E. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.155191 · Cited by 19

Increased Perfluorooctanesulfonate (PFOS) Toxicity and Accumulation Is Associated with Perturbed Prostaglandin Metabolism and Increased Organic Anion Transport Protein (OATP) Expression

Williams, L., Hamilton, M., Edin, M. L., Lih, F. B., Eccles, J. A., Tharayil, N., Leonard, E., & Baldwin, W. S. (2024) · Toxics · doi:10.3390/toxics12020106 · Cited by 18

From persistence to progress: assessing per- and polyfluoroalkyl substances (PFAS) environmental impact and advances in photo-assisted fenton chemistry for remediation

Walker, T., & Milligan, D. K. (2025) · Frontiers in Environmental Chemistry · doi:10.3389/fenvc.2025.1591290 · Cited by 18

Profiling biotoxicities of hexafluoropropylene oxide trimer acid with human embryonic stem cell-based assays

Liang, S., Liang, G., Zhang, Y., Zhang, X., & Zhong, L. (2022) · Journal of Environmental Sciences · doi:10.1016/j.jes.2021.08.012 · Cited by 19

Metabolic effects of nuclear receptor activation in vivo after 28-day oral exposure to three endocrine-disrupting chemicals

Attema, B. J., Kummu, O., Pitkänen, S., Weisell, J., Vuorio, T., Pennanen, E., Vorimo, M., Rysä, J., Kersten, S., Levonen, A., et al. (2024) · Archives of Toxicology · doi:10.1007/s00204-023-03658-2 · Cited by 18

PFAS (per- and polyfluorinated alkyl substances) as EDCs (endocrine-disrupting chemicals) - Identification of compounds with high potential to bind to selected terpenoids NHRs (nuclear hormone receptors)

Buławska, N., Sosnowska, A., Kowalska, D., Stepnik, M., & Puzyn, T. (2024) · Chemosphere · doi:10.1016/j.chemosphere.2024.143967 · Cited by 18

Large-Scale Screening of Per- and Polyfluoroalkyl Substance Binding Interactions and Their Mixtures with Nuclear Receptors

Roy, S., Moran, J., Danasekaran, K., O’Brien, K., & Dakshanamurthy, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158241 · Cited by 17

Associations of Early Life Per- and Polyfluoroalkyl Substances (PFAS) Exposure with Body Mass Index and Risk of Overweight or Obesity at Age 2-18 Years: Mixture Analysis in the Prospective Boston Birth Cohort

Li, Z., Wang, G., Braun, J. M., Hong, X., Choi, G., O’Leary, S. P., Yu, C. H., Pearson, C., Adams, W. G., Fan, Z. (., et al. (2025) · Environment International · doi:10.1016/j.envint.2024.109206 · Cited by 16

Per- and polyfluoroalkyl substances, apolipoproteins and the risk of coronary heart disease in US men and women

Zhu, L., Liu, B., Hu, Y., Wang, M., Furtado, J. D., Rimm, E. B., Grandjean, P., & Sun, Q. (2024) · Environmental Health · doi:10.1186/s12940-024-01147-2 · Cited by 17

Environmental endocrine disruptors and pregnane X receptor action: A review

Liang, Y., Gong, Y., Jiang, Q., Yu, Y., & Zhang, J. (2023) · Food and Chemical Toxicology · doi:10.1016/j.fct.2023.113976 · Cited by 16

Adipogenic and osteogenic effects of OBS and synergistic action with PFOS via PPARγ–RXRα heterodimers

Qin, H., Lang, Y., Wang, Y., Cui, W., Niu, Y., Luan, H., Li, M., Zhang, H., Li, S., Wang, C., et al. (2023) · Environment International · doi:10.1016/j.envint.2023.108354 · Cited by 18

Mixture Effects of Per- and Polyfluoroalkyl Substances on Embryonic and Larval Sheepshead Minnows (Cyprinodon variegatus)

Tanabe, P., Key, P. B., Chung, K. W., Pisarski, E., Reiner, J. L., Rodowa, A. E., Magnuson, J. T., & DeLorenzo, M. E. (2024) · Toxics · doi:10.3390/toxics12010091 · Cited by 17

EFSA Project on the use of NAMs to explore the immunotoxicity of PFAS

Corsini, E., Iulini, M., Galbiati, V., Maddalon, A., Pappalardo, F., Russo, G. L., Hoogenboom, L. A. P., Beekmann, K., Janssen, A. W. F., Louisse, J., et al. (2024) · EFSA Supporting Publications · doi:10.2903/sp.efsa.2024.en-8926 · Cited by 20

To which extent are per-and poly-fluorinated substances associated to metabolic syndrome?

Jeddi, M. Z., Soltanmohammadi, R., Barbieri, G., Fabricio, A. S. C., Pitter, G., Zuanna, T. D., & Canova, C. (2021) · Reviews on Environmental Health · doi:10.1515/reveh-2020-0144 · Cited by 19

Continuous improvement towards environmental protection for pharmaceuticals: advancing a strategy for Europe

Harrison, S., Barnett, C., Short, S., Uluşeker, C., Silva, P. V., Pavlaki, M. D., Roberts, S., Vieira, M., Lofts, S., Loureiro, S., et al. (2025) · Environmental Sciences Europe · doi:10.1186/s12302-025-01180-z · Cited by 16

Cardiometabolic health and per and polyfluoroalkyl substances in an Inuit population

Aker, A. M., Ayotte, P., Caron-Beaudoin, É., Ricard, S., Gaudreau, É., & Lemire, M. (2023) · Environment International · doi:10.1016/j.envint.2023.108283 · Cited by 15

Hepatic Transcriptome Comparative In Silico Analysis Reveals Similar Pathways and Targets Altered by Legacy and Alternative Per- and Polyfluoroalkyl Substances in Mice

Robarts, D. R., Dai, J., Lau, C. S., Apte, U. M., & Corton, J. C. (2023) · Toxics · doi:10.3390/toxics11120963 · Cited by 15

How Per- and Poly-Fluoroalkyl Substances Affect Gamete Viability and Fertilization Capability: Insights from the Literature

Lockington, C., & Favetta, L. A. (2024) · Journal of Xenobiotics · doi:10.3390/jox14020038 · Cited by 15

The Peroxisome Proliferator-Activated Receptors of Ray-Finned Fish: Unique Structures, Elusive Functions

Boukouvala, E., & Krey, G. D. (2024) · Biomolecules · doi:10.3390/biom14060634 · Cited by 14

Candidate Proficiency Test Chemicals to Address Industrial Chemical Applicability Domains for in vitro Human Cytochrome P450 Enzyme Induction

Jacobs, M. N., Kubíčková, B., & Boshoff, E. L. (2022) · Frontiers in Toxicology · doi:10.3389/ftox.2022.880818 · Cited by 17

Integrated science for the study of perfluoroalkyl and polyfluoroalkyl substances (PFAS) in the environment—A strategic science vision for the U.S. Geological Survey

Tokranov, A. K., Bradley, P. M., Focazio, M. J., Kent, D. B., LeBlanc, D. R., McCoy, J. W., Smalling, K. L., Steevens, J. A., & Toccalino, P. L. (2021) · U.S. Geological Survey circular/U.S. Geological Survey Circular · doi:10.3133/cir1490 · Cited by 15

Exposure to per- and polyfluoroalkyl substances and body composition in US adolescents aged 12-18 years: an analysis of data from the National Health and Nutrition Examination Surveys 2011-2018

Lin, L., Cai, L., Liu, Z., Gao, J., Zhou, Y., Zeng, X., Ou, Y., Dong, G., Dong, P., Wu, Q.-Z., et al. (2022) · Hygiene and Environmental Health Advances · doi:10.1016/j.heha.2022.100009 · Cited by 14

Deficiency of spns1 exacerbates per- and polyfluoroalkyl substances mediated hepatic toxicity and steatosis in zebrafish (Danio rerio)

Gadi, S. V., Niture, S. K., Hoang, H., Qi, Q., Hatcher, C., Huang, X., Haider, J., Norford, D. C., Leung, T., Levine, K. E., et al. (2023) · Toxicology · doi:10.1016/j.tox.2023.153641 · Cited by 15

Extracellular vesicles altered by a per- and polyfluoroalkyl substance mixture:in vitrodose-dependent release, chemical content, and microRNA signatures involved in liver health

Carberry, C. K., Bangma, J., Koval, L. E., Keshava, D., Hartwell, H. J., Sokolsky‐Papkov, M., Fry, R. C., & Rager, J. E. (2023) · Toxicological Sciences · doi:10.1093/toxsci/kfad108 · Cited by 15

Determination of in vitro immunotoxic potencies of a series of perfluoralkylsubstances (PFASs) in human Namalwa B lymphocyte and human Jurkat T lymphocyte cells

Janssen, A. W. F., Holleboom, W. J., Rijkers, D., Louisse, J., Hoekstra, S. A., Schild, S., Vrolijk, M. F., Hoogenboom, L. A. P., & Beekmann, K. (2024) · Frontiers in Toxicology · doi:10.3389/ftox.2024.1347965 · Cited by 14

Comparison of transcriptomic profiles between HFPO-DA and prototypical PPARα, PPARγ, and cytotoxic agents in wild-type and PPARα knockout mouse hepatocytes

Heintz, M. M., Klaren, W. D., East, A. W., Haws, L. C., McGreal, S. R., Campbell, R. R., & Thompson, C. M. (2024) · Toxicological Sciences · doi:10.1093/toxsci/kfae045 · Cited by 13

Metabolic changes associated with PFAS exposure in firefighters: A pilot study

Rotander, A., Gómez, M. J., Mueller, J. F., Toms, L.-M. L., & Hyötyläinen, T. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.176004 · Cited by 13

Assessing microplastics, per- and polyfluoroalkyl substances (PFAS), and other contaminants of global concern in wadable agricultural streams in Iowa

Meppelink, S. M., Kolpin, D. W., LeFevre, G. H., Cwiertny, D. M., Givens, C. E., Green, L. A., Hubbard, L. E., Iwanowicz, L. R., Lane, R. F., Mianecki, A. L., et al. (2025) · Environmental Science Processes & Impacts · doi:10.1039/d4em00753k · Cited by 13

Assessment of perfluorooctanoic acid toxicity in pancreatic cells

Abudayyak, M., Öztaş, E., & Özhan, G. (2021) · Toxicology in Vitro · doi:10.1016/j.tiv.2021.105077 · Cited by 13

Exposure to per- and poly-fluoroalkyl substances in association to later occurrence of type 2 diabetes and metabolic pathway dysregulation in a multiethnic US population

Midya, V., Yao, M., Colicino, E., Barupal, D. K., Lin, X., Gennings, C., Chatzi, L., Setiawan, V. W., Loos, R. J. F., Walker, R. W., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105838 · Cited by 13

Environmental exposure to per- and polyfluoroalkyl substances and sleep disturbance in pregnant women: A prospective cohort study

Huang, Y., Nian, M., Yu, G., Tian, Y., Zhang, J., Jiang, F., & Zhang, J. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.156869 · Cited by 13

Perfluorooctanoic acid increases serum cholesterol in a PPARα-dependent manner in female mice

Nielsen, G. H., Gondim, D. D., Cave, M., Heiger‐Bernays, W., Webster, T. F., & Schlezinger, J. J. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-03984-7 · Cited by 15

Potential human health effects of per- and polyfluoroalkyl substances (PFAS) prevalent in aquatic environment: a review

Mayilswami, S., Raval, N. P., Tomar, R., Sharma, S., Praveena, S. M., Kataria, N., Selvasembian, R., Shanmugam, S. R., Nath, R., Malakar, A., et al. (2025) · Environmental Science: Advances · doi:10.1039/d4va00405a · Cited by 11

Hexafluoropropylene oxide tetramer acid (HFPO-TeA)-induced developmental toxicities in chicken embryo: Peroxisome proliferator-activated receptor Alpha (PPARα) is involved

Dong, Q., Guo, Y., Yuan, J., Zhong, S., Ni, H., Liu, J., Zhang, M., Sun, J., Yuan, S., Yu, H., et al. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.114671 · Cited by 12

Association of PFDeA exposure with hypertension (NHANES, 2013–2018)

Li, J., Ye, S., Zhao, Z., Zhao, X. S., Ren, S., Guan, Y., Sun, C., Yao, Q., & Chen, L. (2024) · Scientific Reports · doi:10.1038/s41598-024-51187-4 · Cited by 11

Prenatal per- and polyfluoroalkyl substance exposures and DNA methylation among newborns in the Environmental influences on Child Health Outcomes program

Schrott, R., Ladd‐Acosta, C., Padmanabhan, V., Barr, D. B., Breton, C. V., Cárdenas, A., Carignan, C. C., Dabelea, D., Dunlop, A. L., Fallin, D., et al. (2025) · Current Zoology · doi:10.1093/eep/dvaf010 · Cited by 12

Biological pathways of per- and polyfluoroalkyl substances (PFAS): A critical review of cellular and molecular toxicity mechanisms

Dunmyer, M., Welchert, J., Olivares, C. I., & Karanikola, V. (2026) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2026.141480 · Cited by 12

Exposure to perfluoroalkyl and polyfluoroalkyl substances and risk of stroke in adults: a meta-analysis

Chang, M. C., Chung, S. M., & Kwak, S. G. (2023) · Reviews on Environmental Health · doi:10.1515/reveh-2023-0021 · Cited by 10

Prenatal exposure to Per- and polyfluoroalkyl substances and adiposity measures of children at 4 and 6 years: A prospective birth cohort in China

Sun, S., Xie, Z., Song, X., Wen, S., Yuan, W., Miao, M., Ji, H., & Liang, H. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115751 · Cited by 10

Visceral, Neural, and Immunotoxicity of Per- and Polyfluoroalkyl Substances: A Mini Review

Martano, P., Mahdi, S., Zhou, T., Barazandegan, Y., Iha, R., Do, H., Burken, J. G., Nam, P. K.-S., Yang, Q., & Mu, R. (2025) · Toxics · doi:10.3390/toxics13080658 · Cited by 12

Maternal serum per- and polyfluoroalkyl substances during pregnancy and breastfeeding duration

Friedman, C., Dabelea, D., Keil, A. P., Adgate, J. L., Glueck, D. H., Calafat, A. M., & Starling, A. P. (2023) · Environmental Epidemiology · doi:10.1097/ee9.0000000000000260 · Cited by 10

Association between serum per- and polyfluoroalkyl substances levels and metabolic dysfunction-associated steatotic liver disease

Zhang, J., Cheng, X., Wang, Y., Guo, H. Y., Liu, L., Liu, L., Gao, J., & He, M. (2024) · Environmental Pollution · doi:10.1016/j.envpol.2024.125233 · Cited by 9

Characterisation of the prdx4 gene in Squalius cephalus and its role in freshwater environments with varying impact of perfluoroalkyl substances (PFAS)

Pacchini, S., Vanzan, G., Schumann, S., Piva, E., Bakiu, R., Bertotto, D., Bottacin‐Busolin, A., Irato, P., Marion, A., & Santovito, G. (2025) · Chemosphere · doi:10.1016/j.chemosphere.2025.144167 · Cited by 8

Per- and Polyfluoroalkyl Substances Suppress Macrophage Alternative Activation to Disrupt Hepatic Lipid Metabolism

You, L., Wang, X., Zhi, Y., Wang, H., Zhuang, Z., Yang, J., Zhang, Q., Shang, H., Li, Y., Wan, Y., et al. (2025) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.5c00066 · Cited by 10

Risk-based prioritization of PFAS using phenotypic and transcriptomic data from human induced pluripotent stem cell-derived hepatocytes and cardiomyocytes

Tsai, H.-H. D., Ford, L. C., Chen, Z., Dickey, A. N., Wright, F. A., & Rusyn, I. (2024) · ALTEX · doi:10.14573/altex.2311031 · Cited by 9

Evaluation of Different Extraction Methods for the Analysis of Per- and Polyfluoroalkyl Substances in Dried Blood Spots from the Florida Manatee (Trichechus manatus)

Griffin, E. K., Aristizabal‐Henao, J. J., & Bowden, J. A. (2021) · Environmental Toxicology and Chemistry · doi:10.1002/etc.5175 · Cited by 9

Time-course transcriptome analysis discloses PFDMO2OA (C8 HFPO-TA)-induced developmental malformations and cardiovascular toxicities in zebrafish

Chen, X., Wang, C., Gui, W., Guo, Y., Zhou, X., Zhao, Y., & Dai, J. (2024) · Environmental Pollution · doi:10.1016/j.envpol.2024.123729 · Cited by 7

Toxicological, Chemical, Social, and Economic Challenges Associated with PFAS and Replacement Aqueous Film-Forming Foams (AFFF)

Baldwin, W. S., Bloom, M. S., Chung, K. W., Dasgupta, S., DeLorenzo, M. E., Hunt, K. J., Key, P. B., Pearce, J. L., Rock, K. D., Tanabe, P., et al. (2025) · Toxics · doi:10.3390/toxics13090732 · Cited by 9

Perfluorooctane sulfonate exposure and alcohol-associated liver disease severity in a mouse chronic-binge ethanol feeding model

Ekuban, F. A., Gripshover, T. C., Ames, P., Biswas, K., Bolatimi, O. E., Abramson, J., Iyer, M., Luo, J., Ekuban, A., Hwang, J. Y., et al. (2025) · Toxicological Sciences · doi:10.1093/toxsci/kfaf066 · Cited by 7

Synergistic toxicity in alcohol-associated liver disease and PFAS exposure

Stem, A. D., Tieghi, R. S., Chatzi, V. L., Kleinstreuer, N., Valvi, D., Thompson, D. C., & Vasiliou, V. (2025) · Toxicological Sciences · doi:10.1093/toxsci/kfaf110 · Cited by 7

Impact of PFAS exposure on lipid metabolic pathways: mechanisms and implications in carcinogenesis

Ferguson, E. J., Tessmann, J. W., & Zaytseva, Y. Y. (2026) · Frontiers in Toxicology · doi:10.3389/ftox.2026.1768277 · Cited by 8

Perfluoroalkyl substances (PFASs) decrease the expression of recombination-activating genes (RAG1 and RAG2) in human B lymphoma Namalwa cells

Janssen, A. W. F., Louisse, J., Rijkers, D., Pinckaers, N. E. T., Hoekstra, S. A., Hoogenboom, L. A. P., Peijnenburg, A., & Beekmann, K. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03405-z · Cited by 6

Overview of Modeling, Applications, and Knowledge Gaps for Integrated Large-Scale PFAS Modeling

Raschke, A., Nejadhashemi, A. P., & Rafiei, V. (2022) · Journal of Environmental Engineering · doi:10.1061/(asce)ee.1943-7870.0002033 · Cited by 8

Interactions governing transcriptional activity of nuclear receptors

Khan, S. H., & Okafor, C. D. (2022) · Biochemical Society Transactions · doi:10.1042/bst20220338 · Cited by 7

Endocrine disruption potential of dust in children's indoor environments: Associations with multiple chemicals from various compound classes across exposure matrices used for health risk assessment

Sjöström, Y., Holmes, B. E., Ricklund, N., Struwe, N., Hagström, K., Hagberg, J., & Larsson, M. (2025) · Environmental Research · doi:10.1016/j.envres.2025.121614 · Cited by 5

Human liver perfluorooctane sulfonate associates with steatotic liver disease in a sex-dependent manner

Flam, E. L., Liénard, V., Raverdy, V., Derhourhi, M., Froguel, P., Bonnefond, A., Lefèbvre, P., Pattou, F. N., Eberlé, D., Haas, J. T., et al. (2025) · Environment International · doi:10.1016/j.envint.2025.109838 · Cited by 5

Comparative study on gene expression profiles in the liver of male neonatal mice prenatally exposed to PFOA and its alternative HFPO-DA

Murase, W., Kubota, A., Hakota, R., Yasuda, A., Ikeda, A., Nakagawa, K., Shizu, R., Yoshinari, K., & Kojima, H. (2025) · Toxicology · doi:10.1016/j.tox.2025.154048 · Cited by 5

Association between PFAS exposure and metabolic-related biomarkers in Spanish adolescents

Rodríguez‐Carrillo, A., Vela-Soria, F., Smagulova, F. O., Fernández, M. F., & Freire, C. (2025) · Environmental Research · doi:10.1016/j.envres.2025.121171 · Cited by 6

Relationships between maternal perfluoroalkyl substance levels, polymorphisms of receptor genes, and adverse birth outcomes in the Hokkaido birth cohort study, Japan.

Kobayashi, S., Sata, F., Ikeda-Araki, A., Miyashita, C., Houman, G., Iwasaki, Y., Nakajima, T., & Kishi, R. (2021) · Reproductive Toxicology · doi:10.1016/j.reprotox.2021.12.004 · Cited by 5

Perfluoroalkyl and polyfluoroalkyl substances: the price of forever chemicals

Sheinhaus, D. L., & Gore, A. C. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00125-6 · Cited by 7

Associations of Perfluoroalkyl Substances with Metabolic-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease: NHANES 2017–2018

Zhang, Y., Zhang, M., Jiang, S., Hu, H., Wang, X., Yu, F., Huang, Y., & Liang, Y. (2024) · Cancer Causes & Control · doi:10.1007/s10552-024-01865-5 · Cited by 5

Environmental occurance, human exposure, and metabolism of per- and polyfluoroalkyl substances—a review

Cao, Y., Huang, Y., Ma, Y., Nie, J., Hu, C., Chen, Y., Xu, J., & Lu, L. (2025) · Environmental Research Communications · doi:10.1088/2515-7620/add0fa · Cited by 4

Per- and polyfluoroalkyl substances in dog blood serum levels and semen quality

Weiss, J. M., Engelhardt, J. A., Holst, B. S., Al‐Sarraj, R., & Hallberg, I. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1643703 · Cited by 4

Per- and polyfluoroalkyl substances: A novel risk factor for cardiovascular disease

Chen, W., Qiu, C., Yang, Z., Nash, H., Karim, R., & Chen, Z. (2026) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2026.119955 · Cited by 6

Applying Thermal Proteome Profiling to Per- and Polyfluoroalkyl Substances (PFAS): Proteome-Wide Identification of Molecular Targets and Early Events

Zheng, X., Li, Y., Qin, H., Ruan, C., Yao, L., Liu, X., Ye, M., Qu, G., & Jiang, G. (2026) · Environmental Science & Technology · doi:10.1021/acs.est.5c15707 · Cited by 4

Development of a QSAR model for predicting PPARα activation by PFAS based on human in vitro data of a comprehensive panel of legacy and novel PFAS

Alker, W., Tsiros, P., Sarimveis, H., Braeuning, A., & Buhrke, T. (2026) · Archives of Toxicology · doi:10.1007/s00204-026-04359-2 · Cited by 4

Mode of action Criteria for selection of the critical effect and safe dose range for PFOA by the Alliance for risk assessment

M.A., H. J. C. I. (2024) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2024.105738 · Cited by 5

Perfluorooctane sulfonate and perfluorooctanoic acid

Kuzukıran, Ö., Şimşek, İ., Filazı, A., & Yurdakök-Di̇kmen, B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89773-0.00041-2 · Cited by 4

Introduction to molecular pharmacology: basic concepts

Afzal, M., Kazmi, I. A., Kaur, R. P., Hosawi, S. B. I., Kaleem, M., Alzarea, S. I., & Ahmad, M. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99855-0.00001-4 · Cited by 4

Per- and polyfluoroalkyl substances (PFAS) in drinking water, gestational diabetes mellitus, hypertension and preeclampsia: A nation-wide register-based study on PFAS in drinking water

Säve‐Söderbergh, M., Gyllenhammar, I., Schillemans, T., Lindfeldt, E., Vogs, C., Donat‐Vargas, C., Helte, E., Ankarberg, E. H., Glynn, A. W., Ahrens, L., et al. (2025) · Environment International · doi:10.1016/j.envint.2025.109415 · Cited by 4

Integrated assessment of the effects of PFOA exposure on hepatic transcriptome and lipid profiles in mice expressing human PPARα

Nielsen, G. H., Reed, E. R., Lara, B., Sherr, D. H., Heiger‐Bernays, W., Hyötyläinen, T., Webster, T. F., & Schlezinger, J. J. (2025) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2025.117658 · Cited by 4

Associations of PFAS and phthalate/DINCH metabolites with metabolic regulation in teenagers from the HBM4EU aligned studies

Rodríguez‐Carrillo, A., Cox, B., Hassen, H. Y., Govarts, E., Iszatt, N., Olivas-Martínez, A., Hond, E. D., Verheyen, V. J., Fábelová, L., Palkovičová, Ľ., et al. (2026) · Environment International · doi:10.1016/j.envint.2026.110302 · Cited by 4

Gut Microbiota, Human Blood Metabolites, and Esophageal Cancer: A Mendelian Randomization Study

Xiuzhi, L. I., Xu, B., Yang, H., & Zhu, Z. (2024) · Genes · doi:10.3390/genes15060729 · Cited by 4

Molecular Pathways of Emerging Pollutants in the Marine Ecosystem

Liu, Y., & Pei, D. (2025) · Springer eBooks · doi:10.1007/978-3-031-75713-6_10 · Cited by 3

Perfluorooctanesulfonic acid (PFOS) exposure and multiple sclerosis: Evidence of association and mechanistic insights

Liu, X., Wang, X., & Wang, L. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.119237 · Cited by 3

Extracellular Vesicle ( EV ) Mechanisms of Toxicity for Per and Polyfluoroalkyl Substances: Comparing Transcriptomic Points of Departure Across Global Versus EV Regulatory Gene Sets

Carberry, C. K., Hartwell, H. J., Rider, C. V., Wheeler, M. W., Auerbach, S. S., & Rager, J. E. (2025) · Environmental and Molecular Mutagenesis · doi:10.1002/em.70008 · Cited by 2

Unveiling the Research Void: Exploring the Reproductive Effects of PFAS Compounds on Male Health

Qu, H., Han, Y., Wang, C., Zheng, D., Ni, Y., & Xiao, X. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-82990-1_7 · Cited by 2

Human proteome-wide molecular interaction analysis based on AlphaFold3 to evaluate toxicity between PFOS and its alternative F-53B

Li, H., Chen, N., Yu, B., Peng, Y., Yuan, Y., Guo, H., & Zhang, Z. (2025) · Toxicology · doi:10.1016/j.tox.2025.154308 · Cited by 2

Pharmacokinetics and Pharmacodynamics of Perfluorooctane Sulfonate (PFOS) and Its Role in the Development and Progression of Prostate, Ovarian and Breast Cancers

Arunsi, U. O., Ezirim, D. C., Arunsi, C. C., Altayyar, A., Eke, G., Jonathan, F. C., Opieh, A. K., Anadi, I. V., Ofoegbu, C. O., Nwankwo, V. C., et al. (2025) · Cancers · doi:10.3390/cancers17213507 · Cited by 2

Trophic amplification of Per- and polyfluoroalkyl substances (PFAS) in snails: Unveiling definitive role of photic biofilm response in driving bottom-up effects

Wan, J., Wu, J. F., Wang, Y., Rene, E. R., Zhu, M., & Zhu, N. (2025) · Water Research · doi:10.1016/j.watres.2025.125033 · Cited by 2

Association study of internal exposure levels of perfluoroalkyl substances and blood lipid levels in the elderly population and adverse Outcome pathway analysis

Liu, W., Zheng, Y., Gao, Y., Liu, W., Yu, Z. W., Yu, X., Zhu, H., Yao, Y., Zhu, L., Sun, H., et al. (2026) · Environmental Pollution · doi:10.1016/j.envpol.2026.127644 · Cited by 2

Prenatal Exposure to PFOA Induces Ovarian Function Impairment via the Disruption of the PPARγ/ANGPTL4 Pathway

Qi, T., Fan, H., Xu, W., Huang, Y., Shen, L., Li, S., Zhuang, S., Zhou, J., & Li, C. (2026) · Environment & Health · doi:10.1021/envhealth.5c00576 · Cited by 2

Bioactivity Classification of 2,649 Per- and Polyfluoroalkyl Substances (PFASs) via Quantitative Structure–Activity Relationships and Molecular Docking to Health-Relevant Proteins

Li, W., & Bischel, H. N. (2026) · Environmental Science & Technology Letters · doi:10.1021/acs.estlett.6c00172 · Cited by 2

Do Perfluorinated Chemicals Enhance the Toxicity of Other Contaminants in Aquatic Organisms? A Review

Valle, E. M. A., Ivantsova, E., Pracchia, M. L., Cabello, C., de Oliveira, H. P. M., Codognoto, L., & Martyniuk, C. J. (2026) · Toxics · doi:10.3390/toxics14050373 · Cited by 2

Evaluation of Endocrine Disruptome and VirtualToxLab for Predicting Per- and Polyfluoroalkyl Substances Binding to Nuclear Receptors

Franko, N., Vetrih, M., & Dolenc, M. S. (2025) · Journal of Xenobiotics · doi:10.3390/jox15050136 · Cited by 2

Investigating the effects of Perfluorooctanoic Sulfonate (PFOS) and ethanol on fatty liver disease using a modified NIAAA model.

Gripshover, T. C. (2021) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/3675 · Cited by 1

A group of novel polyfluoroether substances affects lipid metabolism in human hepatocyte HepaRG cells less than classic perfluoroalkyl compounds

Sadrabadi, F., Alker, W., Sprenger, H., Braeuning, A., & Buhrke, T. (2025) · Toxicology in Vitro · doi:10.1016/j.tiv.2025.106024 · Cited by 1

Ecotoxicological Assessment of Perfluorooctane Sulfonate and Perfluorooctanoic Acid Following Biodegradation: Insights from Daphnia magna Toxicity and Yeast Estrogen Screen Assays

Kibambe, M. G., & Momba, M. N. B. (2025) · Water · doi:10.3390/w17233368 · Cited by 1

In Vitro Activity of a Panel of Per- and Polyfluoroalkyl Substances (PFAS), Fatty Acids, and Pharmaceuticals in Peroxisome Proliferator-Activated Receptor (PPAR) Alpha, PPAR Gamma, and Estrogen Receptor Assays

Evans, N., Conley, J. M., Cardon, M., Hartig, P., Medlock-Kakaley, E., & Gray, L. E. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.116136 · Cited by 208

Differential Activation of Nuclear Receptors by Perfluorinated Fatty Acid Analogs and Natural Fatty Acids: A Comparison of Human, Mouse, and Rat Peroxisome Proliferator-Activated Receptor-α, -β, and -γ, Liver X Receptor-β, and Retinoid X Receptor-α

Heuvel, J. P. V., Thompson, J. T., Frame, S. R., & Gillies, P. J. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl014 · Cited by 489

trans-Activation of PPAR and Induction of PPAR Target Genes by Perfluorooctane-Based Chemicals

Shipley, J. M. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfh130 · Cited by 168

Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes

Bjork, J. A., Butenhoff, J. L., & Wallace, K. B. (2011) · Toxicology · doi:10.1016/j.tox.2011.06.012 · Cited by 266

Activation of Mouse and Human Peroxisome Proliferator-Activated Receptors (α, β/δ, γ) by Perfluorooctanoic Acid and Perfluorooctane Sulfonate

Takacs, M. L., & Abbott, B. D. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfl135 · Cited by 396